Sodium alpha-hydroxybenzylphosphinate
7492-18-4O=[P+]([O-])C(O)c1ccccc1.[Na+]UKNAYQWNMMGCNX-UHFFFAOYSA-N7492-18-4安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
REACH registered substance: Sodium α-hydroxybenzylphosphinate (EC: 231-313-2)
Sodium alpha-hydroxybenzylphosphinate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
使用The Na salt of α-hydroxybenzylphosphinic acid (Phos) is a prototype. It is harmless. Like insulin, it promotes the formation of glycogen in the isolated rat diaphragm in oxygenated glucose-Ringer solution and decreases the breakdown of glycogen provoked by adrenaline in the diaphragm preparation.
現在のフィルター条件では反応記録がありません。
読み込み中…